Nafcillin Injection, Solution
Product Images NDC 0338-1019

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nafcillin (NDC 0338-1019). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Chemical structure of nafcillin sodium shown as a molecular diagram, including its beta-lactam ring and associated functional groups, with the sodium (Na) and water molecule (H2O) indicated.*

FDA Label Image

Nafcillin Representative Container Label 0338-1017-41 (Image 02)

Nafcillin Injection, USP 1 g in 50 mL single dose container by Baxter Healthcare Corporation, labeled as iso-osmotic and sterile nonpyrogenic. The label includes storage instructions, dosage information for intravenous administration, and warnings against freezing and reuse. NDC 0338-1017-41 and code 2G3540 are visible on the label. Made in USA.*

FDA Label Image

Representative Carton Label 0338-1017-04 Panel 1 Of 2 (Image 03)

Nafcillin Injection, USP 1 g single-dose container, labeled for storage at or below 20°C (68°F) with warnings against thawing by immersion in water baths or microwave irradiation. The label shows it is manufactured by Baxter Healthcare Corporation, Deerfield, IL, USA.*

FDA Label Image

Representative Carton Label 0338-1017-04 Panel 2 Of 2 (Image 04)

Drug facts text panels for Nafcillin Sodium Injection, 2 g/100 mL, in GALAXY Container by Baxter Healthcare Corporation. Each 50 mL contains Nafcillin Sodium USP equivalent to 1 g Nafcillin, plus Dexrose Hydrous and other buffers. Instructions indicate intravenous administration by physician, with cautions on usage and leak checks. Label states sterility and nonpyrogenic status and mentions Rx only use.*

FDA Label Image

Representative Container Label 0338-1019-48 (Image 05)

Nafcillin Injection, USP 2 g/100 mL in a single-dose 100 mL container by Baxter Healthcare Corporation. The label includes details on composition, storage instructions, NDC 0338-1019-48, and cautions regarding usage and preparation. The product is sterile and nonpyrogenic, made in the USA.*

FDA Label Image

Representative Carton Label 0338-1019-48 Panel 1 Of 2 (Image 06)

Two Baxter Healthcare Corporation labels for Nafcillin Injection, USP, each showing 2 g strength in 100 mL single-dose containers. Both labels indicate storage instructions to thaw at room temperature or under refrigeration without forcing thaw by immersion or microwave. The product is identified as a sterile, iso-osmotic injection to be stored at or below specified temperatures and not frozen.*

FDA Label Image

Representative Carton Label 0338-1019-48 Panel 2 Of 2 (Image 07)

Drug facts panel for NAFCILLIN 2 g/100 mL in GALAXY container by Baxter Healthcare Corporation. The panel details inactive ingredients, storage information, and cautions about supplement medication and series connections. It emphasizes intravenous use as directed and notes the solution is sterile and nonpyrogenic.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.